AU2001267527A1 - Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions - Google Patents

Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions

Info

Publication number
AU2001267527A1
AU2001267527A1 AU2001267527A AU6752701A AU2001267527A1 AU 2001267527 A1 AU2001267527 A1 AU 2001267527A1 AU 2001267527 A AU2001267527 A AU 2001267527A AU 6752701 A AU6752701 A AU 6752701A AU 2001267527 A1 AU2001267527 A1 AU 2001267527A1
Authority
AU
Australia
Prior art keywords
bordetella
pertactin
parapertussis
bronchiseptica
repeated regions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001267527A
Other languages
English (en)
Inventor
Caroline Boursaux-Eude
Nicole Guiso-Maclouf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Publication of AU2001267527A1 publication Critical patent/AU2001267527A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001267527A 2000-05-25 2001-05-23 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions Abandoned AU2001267527A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20696900P 2000-05-25 2000-05-25
US60/206,969 2000-05-25
PCT/EP2001/006457 WO2001090143A2 (en) 2000-05-25 2001-05-23 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions

Publications (1)

Publication Number Publication Date
AU2001267527A1 true AU2001267527A1 (en) 2001-12-03

Family

ID=22768696

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001267527A Abandoned AU2001267527A1 (en) 2000-05-25 2001-05-23 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions

Country Status (11)

Country Link
US (3) US7070779B2 (de)
EP (1) EP1284993B1 (de)
JP (1) JP2003533990A (de)
AT (1) ATE393166T1 (de)
AU (1) AU2001267527A1 (de)
CY (1) CY1110430T1 (de)
DE (1) DE60133734T2 (de)
DK (1) DK1284993T3 (de)
ES (1) ES2303833T3 (de)
PT (1) PT1284993E (de)
WO (1) WO2001090143A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2646776B1 (fr) * 1989-05-12 1994-06-03 Pasteur Institut Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella
JP2003533990A (ja) 2000-05-25 2003-11-18 インスティチュート・パスツール 百日咳菌、パラ百日咳菌および気管支敗血症菌のペルタクチンの繰返し領域の多型性を有するポリペプチド、ならびに診断および免疫原性組成物におけるその使用
US8465754B2 (en) 2007-05-28 2013-06-18 Kitasato Daiichi Sankyo Vaccine Co., Ltd. Bordetella parapertussis whole-cell vaccine composition
CU23679A1 (es) * 2007-10-30 2011-07-11 Ct Ingenieria Genetica Biotech Variantes de pertactinas para uso vacunal
EP2430040A1 (de) * 2009-05-11 2012-03-21 Novartis AG Antigenaufreinigungs­verfahren für pertactinantigen
US8261986B2 (en) * 2009-10-21 2012-09-11 Kevin Kwong-Tai Chung System and method for decoding an optically readable markable sheet and markable sheet therefor
DK2670432T3 (da) * 2011-02-04 2021-04-19 Zoetis Services Llc Immunogene Bordetella bronchiseptica-sammensætninger
KR20130112950A (ko) * 2011-02-04 2013-10-14 조에티스 엘엘씨 개 호흡기 복합 질환용 조성물
CN109879942A (zh) * 2019-03-01 2019-06-14 浙江省农业科学院 一种兔波氏杆菌外膜蛋白及其制备方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9007416D0 (en) * 1990-04-02 1990-05-30 Wellcome Found Expression of heterologous protein in yeast
GB9027901D0 (en) * 1990-12-21 1991-02-13 Wellcome Found Acellular vaccine
FR2728170A1 (fr) * 1994-12-15 1996-06-21 Pasteur Institut Vaccin de type acellulaire anti-bordetella
JP2003533990A (ja) * 2000-05-25 2003-11-18 インスティチュート・パスツール 百日咳菌、パラ百日咳菌および気管支敗血症菌のペルタクチンの繰返し領域の多型性を有するポリペプチド、ならびに診断および免疫原性組成物におけるその使用

Also Published As

Publication number Publication date
EP1284993B1 (de) 2008-04-23
US20030180307A1 (en) 2003-09-25
WO2001090143A2 (en) 2001-11-29
US7314910B2 (en) 2008-01-01
ES2303833T3 (es) 2008-09-01
PT1284993E (pt) 2008-06-11
EP1284993A2 (de) 2003-02-26
CY1110430T1 (el) 2012-05-23
DE60133734T2 (de) 2009-05-14
WO2001090143A3 (en) 2002-09-26
US20040166116A9 (en) 2004-08-26
US6964767B2 (en) 2005-11-15
US20060008474A1 (en) 2006-01-12
DK1284993T3 (da) 2008-07-28
DE60133734D1 (de) 2008-06-05
US20020192237A1 (en) 2002-12-19
US7070779B2 (en) 2006-07-04
JP2003533990A (ja) 2003-11-18
ATE393166T1 (de) 2008-05-15

Similar Documents

Publication Publication Date Title
CY1110430T1 (el) Πολυπεπτιδια περιεχοντα πολυμορφισμους των επαναλαμβανομενων περιοχων της περτακτινης σε bordetella pertussis, bordetella paraperussis kai bordetella bronchiseptica. χρηση αυτων σε διαγνωστικες και ανοσογονες συνθεσεις
MXPA03005222A (es) Derivado de metanosulfonamido-benzofurano, su procedimiento de preparacion y su utilizacion como intermediario de sisntesis.
MXPA02010826A (es) Compuestos y metodos para el tratamiento y la prevencion de infeccion bacteriana.
MXPA04004106A (es) Composiciones cosmeticas anhidras que contienen polioles.
AU5242000A (en) Nematicidal trifluorobutenes
NL300605I2 (de)
WO2002032898A3 (de) Neue anticholinergika, verfahren zu deren herstellung und deren verwendung als arzneimittel
AU1199900A (en) Use of purified invaplex from gram negative bacteria as a vaccine
MXPA02011370A (es) Iminoazinas substituidas.
WO2005046371A3 (en) Personal protection system and method for using a personal protection system
ZA959729B (en) Immunogenic compositions
MY136386A (en) New combination of a betablocker and a cholesterol-lowering agent
EP1762620A3 (de) Antigene aus Cryptosporidium parvum, Antikörper dagegen und diagnostische und therapeutische Zusammensetzungen
BR0016971A (pt) Método aperfeiçoado para ansiedade
TW200501943A (en) Escitalopram hydrobromide and a method for the preparation thereof
WO2002022150A3 (de) Arzneimittel enthaltend aktiviertes antithrombin iii
EP1303300A4 (de) Zusammensetzungen und methoden zur behandlung von candidosen
AU5625796A (en) Protective epitopes of adenyl cyclase-haemolysin(AC-Hly), their application to the treatment or to the prevention of bordetella infections
MX9802543A (es) Deteccion, prevencion y tratamiento de dermatitis digital papilomatosa.
MXPA02012015A (es) Ligandos de receptores para integrinas.
NZ514027A (en) Cloning and expression of haemophilus somnus transferrin-binding proteins
Chapman et al. Silence at Ramscliffe
MXPA04000384A (es) Formulacion de medicamento que contiene antagonista de ltb4.
ZA200201384B (en) 1,4-dioxacycloalkane-2-one and 1,4-dioxacyloalkene-2-one.
RU2000109224A (ru) Способ дезинтоксикации нейтрализацией микробных токсинов